SCHEMBL6993972

SCHEMBL6993972

Cc1ccc(Cc2cc3ccc(F)cc3[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.44
DDO Q99489 2/20 0.44
ITK Q08881 1/20 0.43
NR3C1 P04150 2/20 0.41
PGR P06401 2/20 0.41
NR3C2 P08235 2/20 0.41
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPY5R Q15761 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
PCSK9 Q8NBP7 2/20 0.38
IDO1 P14902 1/20 0.38
RET P07949 1/20 0.37
MAPT P10636 1/20 0.37
KDR P35968 1/20 0.37
KIF11 P52732 1/20 0.37
CNR1 P21554 1/20 0.37
ACHE P22303 1/20 0.36
ALKBH3 Q96Q83 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6994150 0.91 DAO (0.44) DAODDOITKNR3C1PGR
SCHEMBL6990951 0.90 DAO (0.49) DAODDONR3C1PGRNR3C2
SCHEMBL6993553 0.81 PTGS2 (0.50) DAODDOCNR1
SCHEMBL6995615 0.81 LOXL2 (0.57) DAONR3C1PGRNR3C2KDM4E
SCHEMBL7502282 0.79 PCSK9 (0.57) LOXL2PCSK9CNR1
SCHEMBL7487224 0.78 MAP2K4 (0.47) DAODDONR3C1PGRNR3C2
SCHEMBL6992345 0.78 SIGMAR1 (0.46) DAODDOLOXL2PCSK9CNR1
SCHEMBL6943878 0.78 DAO (0.40) DAODDONPY5RIDO1CNR1
SCHEMBL4803301 0.77 SRD5A2 (0.51) DAODDOITKKDM4EMAPT
SCHEMBL549051 0.76 DAO (0.47) DAODDOITKNR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322646-A1 2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2003-07-02 EP disclosed
WO-2002008225-A1 2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2002-01-31 WO disclosed